{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Angiogenesis > AC1NS4RECAS：1055412-47-9
Molecular Formula：C15H13ClN2O
Molecular Weight：272.73
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：Brown to black Solid
Qty：
Size：
| CAS | 1055412-47-9 |
| Name | AC1NS4RE |
| Molecular Formula | C15H13ClN2O |
| Molecular Weight | 272.73 |
| Solubility | Soluble in DMSO ≥1mg/mL(Need ultrasonic or Water bath) |
| Purity | ≥98% |
| Appearance | Brown to black Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| MDL | MFCD08443928 |
| SMILES | CC1=CC(=C(N1)/C=C2/C3=C(C=CC(=C3)Cl)NC2=O)C |
| InChIKey | XLBQNZICMYZIQT-GHXNOFRVSA-N |
| InChI | InChI=1S/C15H13ClN2O/c1-8-5-9(2)17-14(8)7-12-11-6-10(16)3-4-13(11)18-15(12)19/h3-7，17H，1-2H3，(H，18，19)/b12-7- |
| PubChem CID | 6536806 |
| Target Point | FLT3 |
| Passage | Angiogenesis; Protein Tyrosine Kinase/RTK |
| Background | SU5614 is a PTK inhibitor of FLT3 and has antiproliferative and proapoptotic activity in AML-derived cell lines that endogenously express an activated FLT3 receptor[1]. |
| Unit | Bottle |
| Specification | 25mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
